Xilio Therapeutics, Inc. (XLO): Price and Financial Metrics

Xilio Therapeutics, Inc. (XLO): $1.04

0.25 (-19.38%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add XLO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#51 of 329

in industry

XLO Price/Volume Stats

Current price $1.04 52-week high $2.04
Prev. close $1.29 52-week low $0.49
Day low $0.90 Volume 1,217,972
Day high $1.29 Avg. volume 541,067
50-day MA $0.88 Dividend yield N/A
200-day MA $0.92 Market Cap 45.71M

XLO Stock Price Chart Interactive Chart >


Xilio Therapeutics, Inc. (XLO) Company Bio


Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cytokine programs comprise XTX202, XTX301, and XTX401, which are modified form of IL-2 that is masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.


XLO Latest News Stream


Event/Time News Detail
Loading, please wait...

XLO Latest Social Stream


Loading social stream, please wait...

View Full XLO Social Stream

XLO Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!